Pulse oximetry for diagnosis of Critical Congenital Heart Disease

Abstract

Background: Critical Congenital heart disease (CCHD) includes severe disorders that require early identification to enhance early detection of CCHD, and early interference to optimize neonatal outcomes. Objective: To evaluate the accuracy of pulse oximeter in detecting CCHD in neonates. Patients and methods: all neonates delivered at Aswan University Hospital were recruited. The screening was performed by (Pulse oximetry) PO and echocardiography (ECHO) between 24 and 72 hours of age. Results: Among the 100 screened newborn, it was found that 5 true positive and 95 true negative cases. PO test for CCHD had a sensitivity of 100%, a specificity of 100%, a positive predictive value of 100%, and a negative predictive value of 100%. Conclusion: PO is a noninvasive and harmless, practicable tool to screen CCHD and diagnose clinically undetectable CCHD in newborns.

Neonatal Pulse Oximetry Screening for Congenital Heart Disease

“…They advocate it as a screening tool in asymptomatic babies prior to hospital discharge. Furthermore, Name of the author [25] discovered that Pulse oximetry (PO) offers 100% sensitivity, 100% specificity, 100% positive predictive value, and 100% negative predictive value-when compared to echocardiography, the gold standard test. That was by Name of the author [26] reported that the sensitivity was not applicable, and the specificity was 99.4%.…”